Alnylam Pharmaceuticals | ALNY - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Amgen USD 19.52B 1.37B 2026-03
Arrowhead Research USD 30.75M 2.19M 2026-03
BioCryst Pharmaceuticals USD 10.96M 4.87M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Incyte USD 228.62M 1.41B 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Moderna USD 161M 156M 2026-03
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novartis USD 4.32B 134M 2026-03
PTC Therapeutics USD 25.48M 20M 2026-03
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.71B 219M 2026-03
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Takeda JPY 491.34B 23.75B 2026-03
Tectonic Therapeutic USD 2.55M 1.46M 2026-03
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03
Xencor USD 7.92M 2.91M 2026-03